In another study, i.v. injection of a replicating AdV expressing an anti-murine CTLA-4 mAb delayed tumor growth in syngeneic mouse models, and led to complete regressions when combined with a virus encoding GM-CSF. Here, CTLA4 is linked to neoplasm.